The average one-year price target for Co-Diagnostics (OTCPK:CODX) has been revised to $30.60 / share. This is a decrease of ...
In recent trading, shares of Quest Diagnostics, Inc. (Symbol: DGX) have crossed above the average analyst 12-month target price of $159.00, changing hands for $160.14/share. When a stock reaches the ...
The average one-year price target for Bluejay Diagnostics (NASDAQ:BJDX) has been revised to 61.20 / share. This is an increase of 1,900.00% from the prior estimate of 3.06 dated July 5, 2023. The ...
Investing.com - Ascendiant Capital has raised its price target on Lucid Diagnostics Inc (NASDAQ:LUCD) to $8.25 from $8.00 while maintaining a Buy rating on the stock. This target represents a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results